In an era of open data, genome-wide association studies have become entangled with efforts to prove Black inferiority.

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS ® platform to develop in vivo gene editing therapies for high unmet need ...

Veracyte, Inc. , a leading cancer diagnostics company, today announced new data showing that its whole-genome sequencing (WGS)-based platform for minimal residual disease (MRD) testing detected cancer ...

The pending economic failure of a company built on customers retracing their genetic pasts could pose a future security ...

Scientists at deCODE genetics, a subsidiary of Amgen, reveal today in Nature Genetics associations between bipolar disorder and rare loss-of-function variants in two genes.

Research conducted as part of a unique partnership between the Center for Integrative Brain Research at Seattle Children's and data scientists at Microsoft sheds new light on Sudden Infant Death ...

ELRIG meeting on Therapeutic Oligonucleotides brings together esteemed scientists from academia, industry, and other members ...

The British Horseracing Authority (BHA) is expanding its world-leading equine Anti-Doping programme to include testing for ...

The University of Texas MD Anderson Cancer Center and The University of Texas at Austin have launched a joint initiative, the ...

Expanding CRISPR's Potential Since its discovery, CRISPR (“Clustered Regularly Interspaced Short Palindromic Repeats”), which ...

In this week’s edition of the biotech bi-weekly, learn more about Thermo Fisher’s new system for automating complex sample ...